Status:
COMPLETED
Pulse Wave Parameters in the Assessment of Systolic Function of the Left Ventricle.
Lead Sponsor:
I.M. Sechenov First Moscow State Medical University
Conditions:
Hypertension
Heart Failure
Eligibility:
All Genders
18+ years
Brief Summary
This is a prospective, single-center, non-randomized, observational study. The aim of this study is to determine the potential of a single-lead electrocardiogram monitor CardioQvark with photoplethysm...
Detailed Description
The aim of this study is to determine the potential of a single-lead electrocardiogram (ECG) monitor CardioQvark (Moscow, Russia) with photoplethysmography function use to evaluate parameters systolic...
Eligibility Criteria
Inclusion
- The presence of written informed consent of the patient to participate in the study.
- The presence of diagnosed cardiac pathology according anamnesis (coronary artery disease (I-IV classes according Canadian Cardiovascular Society grading of angina pectoris, post myocardial infarction, patients after percutaneous coronary intervention or coronary artery bypass grafting); hypertension (stages I- III); valvular heart disease (except patients with aortic valve stenosis and mechanical prosthetic heart valve); heart failure (I-IV NYHA).
- \-
Exclusion
- 1\. Patient's reluctance to participate in the study. 2. Poor quality of ECG recording by a single-channel ECG monitor. 3. Poor visualization of the heart during echocardiography.
- \-
- Non-inclusion criteria:
- The presence of rhythm and conduction disorders (WPW syndrome, frequent premature ventricular complexes, 2nd and 3rd degree sinoatrial block, 3rd degree atrioventricular block, complete left bundle branch block, complete right bundle branch block).
- Patients with permanent cardiac pacemaker, cardio-resynchronization therapy (CRT), implantable cardioverter-defibrillator (ICD).
- Conditions that can impair ECG recording quality (Parkinson's disease, essential tremor, etc.) or conditions that make it difficult to record ECG and photoplethysmogram (traumatic arm amputation)
- Mental illness (diagnosed early)
- Diseases with a life expected expectancy of less than 2 years.
- Pregnancy.
Key Trial Info
Start Date :
December 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 31 2021
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT04788342
Start Date
December 1 2019
End Date
July 31 2021
Last Update
December 7 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Moscow, Russia